Top Clinical Trials companies in France by Capital Expenditure

This ranking features the top 19 Clinical Trials companies in France ranked by Capital Expenditure, totaling a Capital Expenditure of USD -21.97 M, for February 06, 2025.
#
Name
Capital Expenditure
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD -7.07 M
Dec. 31, 2023 USD 2.03 3.98%

France

2
USD -2.75 M
Dec. 31, 2023 USD 3.91 3.55%

France

3
USD -2.59 M
Dec. 31, 2023 USD 2.01 -0.78%

France

4
USD -1.43 M
Dec. 31, 2023 USD 3.55 2.04%

France

5
USD -1.42 M
Dec. 31, 2023 USD 2.06 -0.75%

France

6
USD -1.29 M
March 31, 2024 USD 16.83 1.50%

France

7
USD -1.21 M
Dec. 31, 2023 USD 7.66 0.25%

France

8
USD -853.73 K
Dec. 31, 2023 USD 0.65 1.19%

France

9
USD -677.00 K
Dec. 31, 2023 USD 4.22 -0.94%

France

10
USD -596.02 K
Dec. 31, 2023 USD 2.43 0.68%

France

11
USD -380.79 K
Dec. 31, 2023 USD 1.64 4.90%

France

12
USD -362.03 K
Dec. 31, 2023 USD 3.47 -1.52%

France

13
USD -292.49 K
Dec. 31, 2023 USD 5.91 -2.66%

France

14
USD -290.29 K
Dec. 31, 2023 USD 1.39 1.77%

France

15
USD -256.07 K
Dec. 31, 2023 USD 6.63 -0.22%

France

16
USD -203.09 K
Dec. 31, 2023 USD 1.45 1.71%

France

17
USD -172.19 K
Dec. 31, 2023 USD 5.64 -2.27%

France

18
USD -97.13 K
Dec. 31, 2023 USD 2.58 -11.21%

France

19
USD -46.84 K
Dec. 31, 2023 USD 3.87 -3.39%

France

Frequently Asked Questions
  • Which Clinical Trials company in France has the highest Capital Expenditure ?

    The Clinical Trials company in France with the highest Capital Expenditure is Crossject SA (Paris Stock Exchange: ALCJ.PA) at USD -7.07 M.

  • Which Clinical Trials company in France has the lowest Capital Expenditure ?

    The Clinical Trials company in France with the lowest Capital Expenditure is Predilife S.A. (Paris Stock Exchange: ALPRE.PA) at USD -46.84 K.

SV Wall Street